Low-temperature inhalation administration of cannabinoid entities
Abstract:
A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.
Public/Granted literature
Information query
Patent Agency Ranking
0/0